PORTAL VEIN THROMBOSIS
Clinical trials for PORTAL VEIN THROMBOSIS explained in plain language.
Never miss a new study
Get alerted when new PORTAL VEIN THROMBOSIS trials appear
Sign up with your email to follow new studies for PORTAL VEIN THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood thinner trial aims to prevent rebleeding in liver patients
Disease control Not yet recruitingThis study tests whether the blood thinner rivaroxaban can safely improve outcomes in people with liver cirrhosis who have both a blood clot in the portal vein and a high risk of variceal bleeding. About 175 participants will receive rivaroxaban or standard care starting 48 hours…
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Massive study aims to predict deadly clots in liver patients
Knowledge-focused Not yet recruitingThis study will follow about 2,500 adults with liver cirrhosis to learn who gets dangerous blood clots in the liver's main vein, how these clots affect survival, and whether blood-thinner medications are safe and helpful. Participants receive no experimental treatment—just routin…
Matched conditions: PORTAL VEIN THROMBOSIS
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC